Ozaki Y, Aoyama Y, Masuda J, Inagaki L, et al. Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study. BMC Cancer 2022;22:36.
PMID: 34983437